Received: 29 May 2019
Accepted: 20 April 2020
First Online: 18 May 2020
Ethics approval and consent to participate
: The study was conducted according to the Declaration of Helsinki and approved by the Royan Institute’s ethics committee (ref: ExternalRef removed.ACECR.ROYAN.REC.1396.98). Informed written consent was obtained from all participants.
: Not applicable.
: SMKR serves as the chief science officer at Cognetivity ltd; CK serves as Chief Medical Officer at Cognetivity Ltd. Other authors declared no potential conflicts of interest.